Yantai Zhigong Biopharmaceutical Technology Co., Ltd.

Cherish life, prioritize health.

Focusing on precision prevention and treatment of cancer, Healthy China for Every Household

Focus, Professionalism, Excellence, Innovation

Sharing cutting-edge technologies and championing early cancer screening products.

Video

About Us

Establish a national-level “specialized, refined, distinctive, and innovative” enterprise centered on innovative molecular diagnostics for reproductive tract tumors, with coverage spanning multi-omics testing instruments and associated reagent kits.

Yantai Zhigong Biopharmaceutical Technology Co., Ltd. is a company co-founded by returned overseas scholars and experts in the biopharmaceutical industry, and also serves as the Yantai technology-transfer base for Baiyuan Gene. The company is pioneering uncharted territory in the cancer‑related field, addressing critical gaps in clinical diagnostics for bladder cancer. Building on its research in bladder cancer genomics and the development of early‑diagnosis gene chips, it is advancing the R&D and industrial-scale production of products for bladder cancer risk prediction, prognosis assessment, personalized medication guidance, infection monitoring, and biochemical diagnostics. Committed to becoming a national-level “specialized, refined, distinctive, and innovative” enterprise, the company focuses on cutting-edge molecular diagnostics for reproductive‑tract tumors while expanding into multi‑omics testing instruments and associated reagent platforms.

Instrument Series

Flow cytometer, microbial mass spectrometer, nucleic acid mass spectrometer, enzyme-linked immunosorbent assay analyzer, real-time fluorescent quantitative PCR instrument, and others.

Reagent Series

Flow cytometry antibodies, immunohistochemistry antibodies, microbial culture media, and more.

Instrument Series

Reagent Series

Our Products

Med-Cycle2L8C Flow Cytometer

NAE-9600 Microbial Mass Spectrometer

NTSPECTOF 9600 Nucleic Acid Mass Spectrometer

Blog

Good News | Zhigong Bio’s NTSPECTOF 9600 Fully Automated Nucleic Acid Mass Spectrometry Platform Has Been Certified!

With approval from the Shandong Provincial Medical Products Administration, the “Fully Automated Time-of-Flight Mass Spectrometry Detection System,” independently developed by Yantai Zhigong Biopharmaceutical Technology Co., Ltd., obtained a Class II medical device registration certificate on May 11, 2026, under registration number Lu Xie Zhu Jun 20262220159.

Deepening University–Enterprise Collaboration to Jointly Promote Technology Transfer: An Expert Team from Shandong University of Traditional Chinese Medicine Conducts a Research and Exchange Visit to Yantai Zhigong Biopharmaceutical Technology Co., Ltd.

On the afternoon of April 2, a multidisciplinary team of experts led by Cheng Kai from the Science and Technology Office of Shandong University of Traditional Chinese Medicine—including Professors Xu Yuxue, Yang Linlin, and Bi Liyan—visited Yantai Zhigong Biopharmaceutical Technology Co., Ltd. (hereinafter referred to as “Yantai Zhigong”) to conduct an on-site research visit and hold cooperative discussions.

Zhigong Bio Concludes at the 2026 CACLP Exhibition | The Highlights Don’t End Here—The Future Looks Promising!

On March 23, the 23rd CACLP, which drew global attention to the IVD industry, concluded successfully at the Xiamen International Exhibition Center. This year’s event, themed “Moving Forward with Innovation, Achieving Long-Term Success through Quality,” brought together over 1,000 companies spanning the entire IVD value chain from around the world. Zhugong Bio made a striking appearance with its core product portfolio, closing the show on a strong note and earning widespread attention and high praise from industry peers.

Good News | Zhigong Bio Wins the “Technological Innovation Award” at the National Unicorn Enterprise Competition

On December 14, the finals of the 2025 National Unicorn Enterprise Competition concluded successfully in Ningbo High-tech Zone. Yantai Zhigong Biopharmaceutical Technology Co., Ltd. stood out among nearly 140 shortlisted companies recommended by expert panels nationwide, thanks to its groundbreaking technological advances in the biopharmaceutical field. The company was awarded the “Technological Innovation Award” in this competition, earning a highly prestigious accolade for Yantai’s biopharmaceutical industry.

Good News: Zhigong Bio’s Three Innovative Pioneers Have Secured Malaysia’s “Passport” for the First Time

As China and the Malaysian governments deepen their cooperation on mutual recognition of medical device regulatory systems, leading Chinese medical device companies are seizing unprecedented opportunities for international expansion.

Chen Dexin Conducts a Field Inspection of Science and Technology Innovation and the Commercialization of Research Outcomes

On January 11, Vice Governor Chen Dexin, during a field visit to the Silk Road International Intellectual Property Port and other enterprises, emphasized the need to thoroughly implement the spirit of the Central Economic Work Conference, earnestly carry out the arrangements and requirements set forth at the Fourth Plenary Session of the 14th Provincial Party Committee and the Provincial Economic Work Conference, and deepen the integrated development of technological innovation and industrial innovation. He called for further strengthening enterprises as the main actors, bolstering platform support, and improving innovation‑related services, so as to promote the synergistic integration and mutual reinforcement of the innovation chain, industrial chain, financial chain, and talent chain, thereby building momentum and empowering high‑quality industrial development through advanced scientific and technological innovation.

Welcoming talented individuals from all over.

We regard every employee as the company’s most valuable asset. Through a strategic talent management system, we create clear pathways for growth—from potential to capability—empowering you with structured training and rewarding you with competitive compensation. We are committed to building a comprehensive growth ecosystem that spans your entire career journey, ensuring that talent finds its stage and that every effort is duly recognized.

YANTAI

SUZHOU

LANZHOU

+86-535-8209310

Yantai Zhigong Biomedicine Technology Co., Ltd.

Phone:+86-535-8209310

Email:zhigonggent@126.com

Address: Floor 9, Building 9, Shandong International Biotechnology Park, No. 39, Science Avenue, High-tech Zone, Yantai City, Shandong Province

WeChat Official Account

Cherish life, prioritize health.

Focus, Professionalism, Excellence, Innovation

江苏华频电子科技有限公司

Instrument Series

Reagent Series

Sorry，当前栏目暂无内容!

Sorry，The current column has no content!